Log In
Print this Print this

glucagon injection (G-Pen)

  Manage Alerts
Collapse Summary General Information
Company Xeris Pharmaceuticals Inc.
DescriptionStable liquid glucagon
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat severe hypoglycemia in diabetics
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today